Evidence map›Paper›PMID 27876081›Full record

ArticleParasites & vectors2016

In vitro activity of ten essential oils against Sarcoptes scabiei.

Fang Fang, Kerdalidec Candy, Elise Melloul, Charlotte Bernigaud, Ling Chai, Céline Darmon, Rémy Durand, Françoise Botterel, Olivier Chosidow, Arezki Izri and 2 more

Open access · goldAbstract read
In one paragraph

Article in Parasites & vectors, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 70 citations in OpenAlex.

  1. Article
  2. Phytomedicines and conventional drugs in scabies management.GMS hygiene and infection control · 2026
    Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. In Vitro Efficacy of Terpenes from Essential Oils againstMolecules (Basel, Switzerland) · 2023
    Article
  13. Article
  14. Essential Oils againstMolecules (Basel, Switzerland) · 2022
    Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. The Effects of Commercially AvailableInfection and drug resistance · 2022
    Article
  20. Pathogens (Basel, Switzerland) · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 2 countries.

Fang FangParasitology Department, College of Animal Science and Technology, Guangxi University, Nanning, China.
Kerdalidec CandyParasitology-Mycology Department, AP-HP, Hôpital Avicenne, Bobigny, France.
Elise MelloulResearch group Dynamyc, EA 7380 EnvA, UPEC, UPE, Maisons-Alfort & Créteil, France.
Charlotte BernigaudResearch group Dynamyc, EA 7380 EnvA, UPEC, UPE, Maisons-Alfort & Créteil, France.
Ling ChaiGuangxi Key Laboratory of Traditional Chinese Medicine Quality Standards, Guangxi Institute of Traditional Medical and Pharmaceutical Sciences, Nanning, China.
Céline DarmonResearch group Dynamyc, EA 7380 EnvA, UPEC, UPE, Maisons-Alfort & Créteil, France.
Rémy DurandParasitology-Mycology Department, AP-HP, Hôpital Avicenne, Bobigny, France.
Françoise BotterelResearch group Dynamyc, EA 7380 EnvA, UPEC, UPE, Maisons-Alfort & Créteil, France.
Olivier ChosidowDermatology Department, AP-HP, Henri Mondor Hospital, UPEC, Créteil, France.
Arezki IzriParasitology-Mycology Department, AP-HP, Hôpital Avicenne, Bobigny, France.
Weiyi HuangParasitology Department, College of Animal Science and Technology, Guangxi University, Nanning, China.
Jacques GuillotResearch group Dynamyc, EA 7380 EnvA, UPEC, UPE, Maisons-Alfort & Créteil, France. jacques.guillot@vet-alfort.fr.
Assistance Publique – Hôpitaux de Paris · FRGuangxi University · CNHôpital Avicenne · FRGuangxi University of Chinese Medicine · CNUniversité Paris-Est Créteil · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe development of alternative approaches in ectoparasite management is currently required. Essential oils have been demonstrated to exhibit fumigant and topical toxicity to a number of arthropods. The aim of the present study was to assess the potential efficacy of ten essential oils against Sarcoptes scabiei.

methodsThe major chemical components of the oils were identified by GC-MS analysis. Contact and fumigation bioassays were performed on Sarcoptes mites collected from experimentally infected pigs. For contact bioassays, essential oils were diluted with paraffin to get concentrations at 10, 5, and even 1% for the most efficient ones. The mites were inspected under a stereomicroscope 10, 20, 30, 40, 50, 60, 90, 120, 150, and 180min after contact. For fumigation bioassay, a filter paper was treated with 100 μL of the pure essential oil. The mites were inspected under a stereomicroscope for the first 5min, and then every 5min until 1h.

resultsUsing contact bioassays, 1% clove and palmarosa oil killed all the mites within 20 and 50min, respectively. The oils efficacy order was: clove > palmarosa > geranium > tea tree > lavender > manuka > bitter orange > eucalyptus > Japanese cedar. In fumigation bioassays, the efficacy order was: tea tree > clove > eucalyptus > lavender > palmarosa > geranium > Japanese cedar > bitter orange > manuka. In both bioassays, cade oil showed no activity.

conclusionEssential oils, especially tea tree, clove, palmarosa, and eucalyptus oils, are potential complementary or alternative products to treat S. scabiei infections in humans or animals, as well as to control the mites in the environment.

Indexed as

AcaricidesAnimalsBiological AssayGas Chromatography-Mass SpectrometryHumansOils, VolatilePlant OilsSarcoptes scabieiSurvival AnalysisSwineAcaricidesOils, VolatilePlant OilsContactEssential oilsFumigation bioassaySarcoptes scabiei

Identifiers

PMID27876081
PMCPMC5120413
OpenAlexW2550980682

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.